Tokyo, May 11, 2006 (JCN) - Unitika announced on May 9 the results of its recent research on L-arabinose, a monosaccharide extracted from sugar beet. The research has found that L-arabinose demonstrates a potential to inhibit obesity and type 2 diabetes. Specifically, in a mice experiment, the company confirmed that a 19-week administration of L-arabinose prevents weight gain, reduces the rise of the fasting blood sugar level and the insulin resistance index.
